A citation-based method for searching scientific literature

Mansoor Husain, Andreas L Birkenfeld, Morten Donsmark, Kathleen Dungan, Freddy G Eliaschewitz, Denise R Franco, Ole K Jeppesen, Ildiko Lingvay, Ofri Mosenzon, Sue D Pedersen, Cees J Tack, Mette Thomsen, Tina Vilsbøll, Mark L Warren, Stephen C Bain. N Engl J Med 2019
Times Cited: 364



Yuichiro Yamada, Hideki Katagiri, Yoshiyuki Hamamoto, Srikanth Deenadayalan, Andrea Navarria, Keiji Nishijima, Yutaka Seino. Lancet Diabetes Endocrinol 2020
Times Cited: 30




List of shared articles



Times cited


Pharmacokinetics and Clinical Implications of Oral Semaglutide for Type 2 Diabetes Mellitus.
Jennifer N Clements, Diana Isaacs, Rachel E Hartman, Kennedy Gambill. Clin Pharmacokinet 2021
0

Management of type 2 diabetes with oral semaglutide: Practical guidance for pharmacists.
Michael P Kane, Curtis L Triplitt, Carolina D Solis-Herrera. Am J Health Syst Pharm 2021
1



Optimizing Therapeutic Outcomes With Oral Semaglutide: A Patient-Centered Approach.
Diana M Isaacs, Davida F Kruger, Geralyn R Spollett. Diabetes Spectr 2021
0

Peptidyl and Non-Peptidyl Oral Glucagon-Like Peptide-1 Receptor Agonists.
Hun Jee Choe, Young Min Cho. Endocrinol Metab (Seoul) 2021
0

The Future of Incretin-Based Approaches for Neurodegenerative Diseases in Older Adults: Which to Choose? A Review of their Potential Efficacy and Suitability.
Christine Girges, Nirosen Vijiaratnam, Dilan Athauda, Grace Auld, Sonia Gandhi, Thomas Foltynie. Drugs Aging 2021
0

A Review on the Efficacy and Safety of Oral Semaglutide.
Stephanie Niman, Jennifer Hardy, Rebecca F Goldfaden, Jessica Reid, Mae Sheikh-Ali, David Sutton, Rushab Choksi. Drugs R D 2021
0